Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

2 dividend stocks to buy after Q1 earnings season

2 dividend stocks to buy after Q1 earnings season
Paul L.
Stocks

As the Q1 2026 earnings season plays out, the focus is shifting from short-term performance to long-term income potential, with investors zeroing in on companies that continue to reward shareholders consistently through dividends.

 In a market still shaped by uncertainty, firms with dependable cash flows and a track record of dividend growth are standing out as attractive options for income-focused portfolios.

Against this backdrop, Finbold has highlighted two standout names for their attractive yields and solid fundamentals worth investing in during this season. 

AbbVie (NYSE: ABBV)

AbbVie (NYSE: ABBV) has reinforced its position as a leading dividend payer in the pharmaceutical industry. In February 2026, it declared a quarterly dividend of $1.73 per share, payable on May 15, 2026, to shareholders of record as of April 15.

This brings the annualized payout to $6.92 per share, implying a yield of about 3.3%. At press time, ABBV stock was trading at $208, down nearly 10% year-to-date.

ABBV YTD stock price chart. Source: Finbold.com

The company has increased its dividend by more than 330% since its 2013 spin-off and maintains a 53-year streak of increases, including its predecessor.

AbbVie reported adjusted EPS of $2.71 for the latest quarter, beating estimates of $2.65, while revenue rose 10% year over year to $16.62 billion, also ahead of expectations.

The company initially guided full-year 2026 EPS to $14.37 and $14.57, supported by growth from Skyrizi and Rinvoq, but later lowered guidance to $13.96 and $14.16 after a $744 million in-process R&D charge. First-quarter 2026 EPS guidance was also trimmed to $2.56–$2.60.

Analysts currently forecast 2026 EPS of about $14.59, rising to $16.14 in 2027. 

Despite the revision, AbbVie’s valuation remains modest at roughly 14 times forward earnings, supported by strong free cash flow of around $18.5 billion and solid demand across key therapeutic areas.

Verizon Communications (NYSE: VZ)

Verizon Communications (NYSE: VZ) offers one of the highest yields among large-cap telecoms. 

On January 30, 2026, it declared a quarterly dividend of $0.7075 per share, payable on May 1, 2026, to shareholders of record as of April 10.

The 2.5% increase brings the annualized payout to about $2.83 per share, implying a yield near 6.2%. This marks more than 20 consecutive years of dividend growth.

At the time of reporting, shares of VZ were trading at $45, up more than 12% YTD.

VZ YTD stock price chart. Source: Finbold.com

In its fourth-quarter 2025 results released in late January 2026, Verizon reported adjusted EPS of $1.09, beating estimates of $1.06, with revenue rising 2% year over year to $36.38 billion, slightly ahead of forecasts.

The company guided full-year 2026 EPS to $4.90 and $4.95 and expects mobility and broadband service revenue growth of 2.0% to 3.0%. Consensus estimates now place 2026 EPS around $4.91 and $4.94, increasing to about $5.26 in 2027.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Finbold Career

Join Finbold's newsroom, become a crypto reporter today!

Apply now to join Finbold as a crypto/finance news writer!

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Finbold AI Agent

How AI Price Predictions Work

We use cutting-edge AI models to forecast future prices for stocks and crypto.

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.